Freespira

Based in the United States, Freespira is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Freespira develops an FDA-cleared, medication-free digital therapeutic device and program that delivers a 28-day treatment to reduce or eliminate symptoms of panic disorder, panic attacks, and post-traumatic stress disorder, used by health plans, providers, and employers.